Nimotuzumab Concurrent with Gemcitabine as First-Line Treatment of Locally Advanced or Metastatic Pancreatic Adenocarcinoma by Sánchez, Yamirka, Concepción, Martha L., Amador, Yohan, Piriz, Angel, Rabassa, René, Leyva, Ariel, Arguelles, Odalys, Leblanch, Lisett, Moret, Sheyla, Rivero, Gilberto, Vasallo, Ana L., Martorell, Beatriz, Guerra, Pedro P., Valls, Ana R., Sánchez, Lisset, Saumell, Yaimarelis

Get full text